Universal Sanger sequencing from next-gen sequencing amplicons

US12264357B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12264357-B2
Application numberUS-202117397280-A
CountryUS
Kind codeB2
Filing dateAug 9, 2021
Priority dateDec 28, 2012
Publication dateApr 1, 2025
Grant dateApr 1, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of generating an amplicon for next generation sequencing (NSG) for at least one region of interest comprising: (a) adding to a sample of DNA: (i) a first primer set specific for the region of interest consisting of two primers each comprising a 5′ region encoding an adapter and a 3′ region specific for the region of interest, wherein the first primer set binds with a Tm of about 60° C. immediately upstream and downstream of the region of interest; and (ii) a second primer set consisting of two primers each of which comprises: (A) a 5′ sequence selected from GTAAAACGACGGCCAGT (SEQ ID NO: 1) or AACAGCTATGACCATG (SEQ ID NO: 2); (B) a spacer comprising at least 10 nucleotides; and (C) a 3′ adapter that is substantially identical to the adaptor region, wherein the adapter has a T m of about 55° C. and the second primer set has a T m of at least 70° C.; and (b) performing a plurality of PCR cycles with a first annealing temperature and a second annealing temperature. 2. The method of claim 1 , wherein the adaptor comprises a sequence selected from Table 2. 3. The method of claim 1 , wherein the plurality of PCR cycles comprises about 10 cycles at the first annealing temperature and about 30 cycles at the second annealing temperature. 4. The method of claim 3 , wherein the first annealing temperature is about 55° C. 5. The method of claim 3 , wherein the second annealing temperature is between about 60° C. to about 62° C. 6. The method of claim 1 , wherein the plurality of PCR cycles further comprises: (i) a heating step at about 95° C.; (ii) an extending step for about 10 cycles of: (A) about 95° C.; (B) about 55° C.; and (C) about 72° C., and (iii) an extending step for about 30 cycles of: (A) about 95° C.; (B) between about 60° C. to about 62° C.; and (C) about 72° C. 7. The method of claim 6 , wherein the plurality of PCR cycles further comprises an additional extending step at a temperature of about 75° C. for about 15 minutes. 8. The method of claim 1 , wherein the ratio of the first primer set to the second primer set is greater than 1:1. 9. The method of claim 1 , wherein the two primers of the second primer set comprises the sequences selected from SEQ ID NO: 9 or SEQ ID NO: 10.

Assignees

Inventors

Classifications

  • C12Q1/6869Primary

    Methods for sequencing · CPC title

  • Primer sets for multiplex assays · CPC title

  • Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title

  • C12Q1/6806Primary

    Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • Massive parallel sequencing · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12264357B2 cover?
Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.
Who is the assignee on this patent?
Quest Diagnostics Invest Llc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6869. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).